Asthma: open trials in Israel

7 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT07746687
A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-03
NCT06932263
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Trial Treatment · Phase 2 · AstraZeneca
Research Site, Haifa · Research Site, Jerusalem · Research Site, Kfar Saba · Research Site, Ramat Gan · Research Site, Rehovot
Registry updated 2026-10-30
NCT07444567
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Trial Treatment · Phase 3 · AstraZeneca
Research Site, Haifa · Research Site, Holon · Research Site, Petah Tikva
Registry updated 2026-10-27
NCT07276724
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Trial Treatment · Phase 3 · Generate Biomedicines
Research Site 115, Haifa · Research Site 117, Jerusalem · Research Site 118, Jerusalem · Research Site 111, Kfar Saba · Research Site 124, Petah Tikva · Research Site 105, Ramat Gan · Research Site 128, Tel Aviv
Registry updated 2026-10-22
NCT05757102
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Trial Treatment · Phase 3 · GlaxoSmithKline
GSK Investigational Site, Ashkelon · GSK Investigational Site, Haifa · GSK Investigational Site, Petah Tikva
Registry updated 2026-09-30
NCT07629830
Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations
Trial Treatment · Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center, Tel Aviv, Tel Aviv
Registry updated 2026-09-24
NCT06609239
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Trial Treatment · Phase 2 · Sanofi
Investigational Site Number : 3760006, Ashkelon · Investigational Site Number : 3760008, Haifa · Investigational Site Number : 3760001, Haifa · Investigational Site Number : 3760002, Jerusalem · Investigational Site Number : 3760003, Jerusalem · Investigational Site Number : 3760010, Petah Tikva · Investigational Site Number : 3760004, Rehovot · Investigational Site Number : 3760007, Tel Aviv
Registry updated 2026-09-21

All Asthma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Asthma: open trials in Israel

A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma